The findings offer reassurance for patients who aren't fecal transplant candidates ...

Please provide your email address to receive an email when new articles are posted on . However, this finding did not reach statistical significance, the researchers noted. “This is the first ...

Clostridioides difficile (C. difficile) is a leading cause of illness and death, especially for frail and hospitalized Americans. Now, a new study suggests that the leading antibiotic used to fight it ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Oral metronidazole was comparable to oral vancomycin in patients with Clostridium difficile infection ...

University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin during ...

April 4, 2012 (London, United Kingdom) — Fidaxomicin (Dificid, Optimer Pharmaceuticals) treatment was superior to vancomycin for initial cure, recurrence, and sustained response, according to a ...

WASHINGTON -- Prophylaxis with oral vancomycin (Vancocin) appeared to protect at-risk patients from experiencing a recurrence of Clostridium difficile infection, researchers reported here. The goal of ...

Treatment with ridinilazone was found to significantly decrease the rate of recurrent Clostridioides difficile infection (CDI) compared with vancomycin. Treatment with ridinilazone was found to ...

The combination of vancomycin and fecal microbiota transplantation was found to be superior to fidaxomicin or vancomycin in the treatment of patients with recurrent Clostridioides (formerly ...

Researchers found that vancomycin is no longer superior to metronidazole; the change coincided with the emergence of a hypervirulent strain of C. difficile. Metronidazole and vancomycin have been the ...

The use of oral vancomycin prophylaxis was associated with a significant decrease in the recurrence of Clostridium difficile infection, according to a poster presentation at the Interscience ...